Global Olanzapine Market Report - Forecast to 2027

Global Olanzapine Market Report - Forecast to 2027

ID: MRFR/Pharma/0247-HCRR | April, 2018 | Region: Global | 130 pages | Half-Cooked Research Reports

Global: Olanzapine Market Research Report, by Application (Schizophrenia, Bipolar disorder, other) by types (ZYPREXA tablets, ZYPREXA ZYDIS and ZYPREXA IntraMuscular), by region (Europe, Americas, Asia Pacific and Middle East & Africa) - Forecast to 2027 Report Description


Global Olanzapine Market Report: Overview


Olanzapine, formerly known as Zyprexa is a US Food and Drug administration approved drug used in the treatment of schizophrenia, bipolar disorder and other neurological disorders. Olanzapine is generic and is available under many trade names worldwide. Olanzapine is promoted in various nations, with tablets running from 2.5 to 20 milligrams. Zyprexa (and nonspecific olanzapine) is accessible as an orally-breaking down "wafer" which quickly disintegrates in spit. It is likewise accessible in 10 milligram vials for intramuscular infusion.


The market of Olanzapine has been evaluated as $XX million which includes the XX% of market share from Asia pacific followed by Europe. Olanzapine was firstly introduced in the Europe region in the year 1996 when the high amount of population was suffering from the neurological disorder diseases. China is the largest market for the Olanzapine drug and growing with the compound annual growth rate (CAGR) rate of more than 27% and expected to touch the CAGR of XX% in the forecasted period. Olanzapine has been very effective drug but it also has some negative aspects like agitation, dysarthria with others.


Global Olanzapine Market Report: Market Influencer


The main market influencer for the global Olanzapine market is increase in the population of various countries. As the world population is increasing with the growth rate of more than 1% and people are not getting the complete neutrinos is helping to grow the disease like schizophrenia are forcing the companies to produce more drugs in order to meet the demand and helps the consumer.


As per WHO's statistics, 10% of world population experience the ill effects of different sorts of dysfunctional behaviors. As per the insights distributed by the National Center for Mental Health, China-CDC, the quantity of instances of emotional sicknesses is more than 100 million, among which 16 million experience the ill effects of holergasia. Emotional instability has surpassed malignancy and turned into the greatest danger to human wellbeing, positioning first in the aggregate weight of illness in China.


With the change of ways of life and the expanded anxiety in work and life achieved by world's monetary advancement, the frequency of emotional sickness and mental issues is developing. In this manner, the business sector size of olanzapine in world is relied upon to continue extending in the following couple of years.


Global Olanzapine Market Report: Market Segmentation


For the better understanding of the topic, Global Olanzapine market report has been segmented on the basis of:


· Types


· Application


· Geography


Types of Olanzapine is been categorized as ZYPREXA tablets, ZYPREXA ZYDIS and ZYPREXA IntraMuscular which is available for injections. Olanzapine applications includes (Schizophrenia, Bipolar disorder, among others)


Global Olanzapine Market Report: Regional Analysis


Olanzapine is an essential drug for schizophrenia and entered in the European market first time in the year 1996 followed by Chinese market in the year 1999. Olanzapine is one of the highest growing drugs for schizophrenia in the Asia-Pacific with the aggregate CAGR of more than 26%. Asia-Pacific is the biggest market for Olanzapine as it helps to treat the bipolar disorder or schizophrenia. Asia pacific holds more than 40% of global population and countries like China, India and Japan which is suffering from heavy population is more affected with the schizophrenia and consumes Olanzapine in high quantity. Another big market for Olanzapine is Europe followed by America’s.


Global Olanzapine Market Report: Key Players


The key player in the global Olanzapine market includes:



  • WATSON Pharmaceuticals(Changzhou)

  • Hanson Pharmaceutical (Hanson Pharmaceutical has the biggest piece of the pie of around 44% for deals esteem in 2014)

  • Sandoz

  • Zhejiang Langhua Pharmaceuticals

  • Hansoh Pharmaceutical

  • Aurobindo Pharma

  • Jubilant Lifesciencest

  • Torrent Pharmaceuticals

  • Sun Pharmaceutical

  • Lilly

  • Dr. Reddy’s Laboratories

  • Mylan Pharmaceuticals

  • Apotex Inc.

  • Teva Pharmaceutical


Scope of the Report


 


The report comprises the deep analysis of Olanzapine by the Country level


By Geography


o Americas


Ø North America


o US


o Canada


Ø Latin America


o Argentina


o Brazil


o Mexico


o Rest of LATAM


o Europe


Ø Western Europe


o Germany


o France


o Italy


o Spain


o U.K


o Rest of Western Europe


Ø Eastern Europe


o Poland


o Russia


o Asia – Pacific


Ø Asia


o China


o India


o Japan


o South Korea


o Rest of Asia


Ø Pacific Countries


o Australia


o New Zealand


o Middle East & Africa


Ø Middle East


o Saudi


o Qatar


o UAE


o Rest of Middle East


Ø Africa


o South Africa


o Rest of Africa


Every report of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report also gives a broad study of the different market segments and regions.